There is emerging evidence that α1‐blockers can be safely used in the treatment of
hypertension. These drugs can be used in almost all hypertensive patients for blood …

Comparative Effectiveness and Safety of Monodrug Therapies f... : Medicine Comparative
Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated …

Background: Alpha1-adrenoceptor antagonists (α 1-blockers) are first-line drugs for the
treatment of lower urinary tract symptoms associated with benign prostate hyperplasia …

Full article: Statins are effective in the treatment of benign prostatic hyperplasia with metabolic
syndrome Skip to Main Content Taylor and Francis Online homepage Browse Search Publish …

Aims: Increasing evidence has proposed the components of metabolic syndrome (MtS) as
risk factors for the development of benign prostate hyperplasia (BPH); therefore, it is thought …

Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower
urinary tract symptoms: a double-blind, randomized, placebo-controlled study - PMC Back to …

Purpose To investigate the relationship of improvement in erectile function (EF) with
improvement in lower urinary tract symptoms (LUTS) and to assess the contribution of …

Objective To prospectively investigate the association of endothelial nitric oxide synthase
(eNOS) G894T gene polymorphism with responsiveness to a selective α1‐blocker in men …

Vi har læst artiklen af Hollingsworth JM et al. med stor interesse. Denne informative artikel
indeholder en omfattende gennemgang af den offentliggjorte litteratur om benign …

Leki α 1-adrenolityczne to szeroka grupa substancji, w ramach której możliwy jest optymalny
dobór terapii dla różnych pacjentów z dolegliwościami ze strony dolnych dróg moczowych …